Pharma News

Researchers Grow Miniature Brains From Skin Cells in Labs to Understand Autism Better

  • Posted on: 27 July 2015
  • By: Shalini.Sharma

Most children with Autism Spectrum Disorder (ASD) suffer from a condition known as macrocephaly in which the head is larger than normal. To get a better understanding of the disorder, the signs of risk and for the development of new drugs, researchers at Yale School of Medicine developed "miniature brains" from skin cells of autistic patients.

Antibiotics Consumption may Double the Danger of a Child Contracting Juvenile Arthritis

  • Posted on: 27 July 2015
  • By: Shalini.Sharma

Juvenile arthritis is a form of auto-immune disease that involves chronic inflammation of the joints and eyes that can lead to pain, vision loss and disability. A new study has revealed that taking antibiotics may double the risk of a child contracting juvenile arthritis. The findings are published in Pediatrics.

Plants makes a Mutual Relationship With Good Microbes

  • Posted on: 25 July 2015
  • By: Shalini.Sharma

In normal plants, a defense hormone that keeps bad bacteria out from the surface as well as inside the plant's roots and actively recruits the good ones has been detected by researchers. For the study, the researcher team introduced 38 strains of bacteria that they had isolated from roots grown in the wild soil into a sterile clay. The researchers showed that when they grew plants in that synthetic soil, the presence of salicylic acid determined which microbes colonized the roots. The findings are published in the Science Express.

IOL Chemicals to launch APIs in US market

  • Posted on: 25 July 2015
  • By: Shalini.Sharma

IOL Chemicals and Pharmaceuticals  has received US FDA approval for marketing APIs in US after successful inspection of its ibuprofen manufacturing facility situated at Barnala in Punjab. The said facility at Barnala has also been approved by ANVISA Brazil, WHO and MOH Japan. These approvals will help to build and sustaining the growth by its API business in coming years.

Pages